Close Menu

Or Just Close it Down

After the next round of grant submissions, the US National Heart, Lung, and Blood Institute says it will no longer accept investigator-initiated R21 applications, the agency says. In an announcement, NHLBI says that the point of the R21 grant was to give investigators time and money to produce preliminary data that could then be used to pursue larger studies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.